Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | TACR1 | P25103 | 1/20 | 0.32 |
| ▸ | HTR6 | P50406 | 1/20 | 0.32 |
| ▸ | ARG1 | P05089 | 1/20 | 0.31 |
| ▸ | ARG2 | P78540 | 1/20 | 0.31 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.31 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.31 |
| ▸ | CACNB1 | Q02641 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25027108 | 0.88 | ACHE (0.38) | GBA1 | |
| SCHEMBL29317237 | 0.85 | CYP1A2 (0.33) | GBA1CYP2D6 | |
| SCHEMBL25856382 | 0.80 | TACR1 (0.31) | TACR1 | |
| SCHEMBL25856391 | 0.78 | MEN1 (0.33) | HPGDKMT2AHRH3 | |
| SCHEMBL24267132 | 0.78 | GBA1 (0.36) | GBA1ARG1ARG2CACNA2D1CACNA1B | |
| SCHEMBL24480580 | 0.77 | GNAO1 (0.34) | GBA1CACNA2D1CACNA1BCACNB1 | |
| SCHEMBL29317239 | 0.77 | ACHE (0.41) | GBA1KMT2ACACNA2D1CACNA1BCACNB1 | |
| SCHEMBL25026643 | 0.77 | GBA1 (0.32) | GBA1KMT2ACACNA2D1CACNA1BCACNB1 | |
| SCHEMBL24480693 | 0.76 | GBA1 (0.47) | GBA1HPGDKMT2ASMN1; SMN2TACR1 | |
| SCHEMBL2547787 | 0.74 | CHRM5 (0.39) | GBA1HPGDKMT2ASMN1; SMN2HTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023131167-A1 | COMPOUND FOR INHIBITING AND DEGRADING IRAK4, AND PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL APPLICATION THEREOF | 海思科医药集团股份有限公司 | 2023-07-13 | — | — | WO | disclosed |